ArticleTropical animal health and production2019
Preliminary evidence of the seroprevalence and risk factors associated with Chlamydia abortus infection in goats on the Canary Islands, Spain.
Article in Tropical animal health and production, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- Abortive diseases and their various associated risk factors in small ruminants in Algeria: a systematic review.Tropical animal health and production · 2021Pooled it
- Assessment of seroprevalence and associated risk factors ofOpen veterinary journal · 2025Article
- Individual Genomic Loci, Transcript Levels, and Serum Profiles of Immune and Antioxidant Markers Associated with Bacteria-Induced Abortion in Sheep (Veterinary sciences · 2025Article
- A six-year epidemiological study of selected zoonotic abortifacient agents in ovine and caprine foetuses in Türkiye.Epidemiology and infection · 2024Article
- Seroprevalence and Risk Factors Associated withAnimals : an open access journal from MDPI · 2024Article
- Infectious abortions in small domestic ruminants in the Iberian Peninsula: Optimization of sampling procedures for molecular diagnostics.Frontiers in veterinary science · 2023Article
- Article
- Recent advances and public health implications for environmental exposure to Chlamydia abortus: from enzootic to zoonotic disease.Veterinary research · 2022Review
- Seroprevalence and Risk Factors Associated withPathogens (Basel, Switzerland) · 2021Article
- First Report ofFrontiers in veterinary science · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aims of this cross-sectional study were to estimate the prevalence of IgG antibodies against Chlamydia abortus, the cause of enzootic abortion, in goats and to determine its associated risk factors on the Canary Islands. A total of 325 goats from 11 non-vaccinated herds were sampled and assessed using a commercial ELISA kit. Related data were also obtained for further statistical analysis and associated risk factors to seropositive flocks. For comparison, abortion rates between the vaccinated and non-vaccinated herds were compared. The overall seroprevalence of the unvaccinated herds was 33%, which can be considered as high when compared to other European regions. Associated risk factors such as herd size, management system, diet, and manure removal frequency were found statistically significant. However, no significant differences were found in the abortion rates between vaccinated and non-vaccinated flocks, indicating that other microorganisms could also cause abortions in goats on the region. Despite this, the seroprevalence of C. abortus is relatively high in this limited survey of goat herds and may pose a threat to both human and animals on the Canary Islands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.